Figure 2.
Probability of achieving T-score >−2.5 at TH and LS over 18 mo of treatment with abaloparatide, teriparatide, or placebo in the ACTIVE trial. Abbreviations: ABL, abaloparatide; PBO, placebo; TPTD, teriparatide.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.